Urolithin A Supplement Manufacturer

Urolithin A: a longevity-category ingredient that requires more from a manufacturer than most.

Urolithin A has moved from academic curiosity to commercial supplement category in a short window. The driver: most people cannot produce urolithin A endogenously at meaningful concentrations. Gut bacteria can convert ellagitannins — polyphenols found in pomegranate, walnuts, and berries — into urolithin A, but individual microbiome variation means that conversion either doesn't happen or produces negligible amounts in the majority of adults. The supplement category was built on that gap: deliver urolithin A directly, bypassing the conversion bottleneck.

What that means for manufacturing: urolithin A is a specialty raw material, not a commodity. Sourcing it requires qualified suppliers. Identity and potency testing is not optional — the commercial story for this ingredient is built on dose precision and documented quality. Sun Nutraceuticals produces urolithin A supplements in capsule and powder formats at its FDA-registered, cGMP-compliant facility in Fort Lauderdale, Florida.

Capsule or powder — two formats for urolithin A

Urolithin A's typical clinical dose of 500mg to 1,000mg per day makes capsule the natural primary format. One or two capsules at standard size-00 fill weights delivers a full serving. The powder format serves brands building multi-ingredient longevity blends or positioning a daily powder ritual around mitochondrial health.

Urolithin A program types

Production specifications

MOQ	5,000 units
Ingredient forms	Urolithin A (standardized), pomegranate extract (ellagitannin precursor), multi-ingredient longevity blends
Capsule shell materials	Gelatin (bovine/porcine), HPMC (vegetarian), pullulan (vegan-certifiable)
Capsule sizes	Size 00 standard for urolithin A; sizes 0, 1, 2 on request
Typical serving dose	500mg–1,000mg urolithin A per day (one to two capsules at standard fill weights)
Powder packaging	Stand-up pouches — 30-serving and 60-serving configurations
Bottle packaging	HDPE or PET bottles — 30-count, 60-count, 90-count configurations
Third-party testing	Every batch — urolithin A identity and potency, microbial safety panel, label claim validation
Lead time	6–8 weeks from formula approval and component arrival
Documentation	Batch records and Certificate of Analysis with every production run

The urolithin A manufacturing process from brief to finished goods

1. Discovery call. We discuss your formula or concept, format (capsules, powder, or both), target dose per serving, packaging configuration, and MOQ. We quote within one business day — specific line-item costs, not a range that requires follow-up to interpret. Urolithin A raw material pricing varies by grade and available supply; we advise on realistic cost-per-unit expectations before you commit to a program.
2. Formula review or development. If you bring a complete formula, we review it for raw material compatibility, fill weight, and blend flow characteristics before component costing. If you're starting from a brief, we develop the formula — selecting urolithin A grade, dose per serving, excipients, and capsule configuration — and produce bench samples for your approval.
3. Sample approval. You receive production-representative samples. Review, verify the dose and format, and sign off. Once the formula specification is locked, no changes are made without a new sample approval cycle. For a clinical-evidence-positioned ingredient like urolithin A, this step is worth getting right before committing to a production run.
4. Raw material qualification. Urolithin A raw material from the qualified supplier is received and identity-tested before entering production. This incoming quality check is a cGMP requirement and the first layer of batch documentation. We hold qualified supplier relationships for urolithin A to reduce lead time exposure on specialty ingredients.
5. Component procurement. Capsule shells, pouches, bottles, and labels are sourced in parallel with raw material qualification. Label artwork review and approval happen at this stage so finished labels are ready when production completes.
6. Production. Blending and filling run on our in-house production lines under full cGMP batch documentation. For multi-ingredient blends, blend uniformity is verified before fill commences. In-process weight checks run throughout the production run to confirm consistent per-capsule fill weights across the batch.
7. Third-party testing. Every batch goes to an independent accredited laboratory for urolithin A identity and potency verification, microbial safety panels, and label claim validation. Certificate of Analysis is provided before shipment. For a category positioned on clinical research and dose precision, third-party documentation is part of the brand's credibility story.
8. Packaging, labeling, and case-packing. Finished units are labeled and case-packed to your retail or DTC configuration — FBA-ready pallets, retail display cases, or individual DTC shipper cartons. We accommodate FNSKU labeling for Amazon programs.
9. Fulfillment. Finished goods can move from our facility to your warehouse, to Amazon fulfillment centers, or to consumers and retailers through Sun's integrated fulfillment operation.

What buyers look for in an urolithin A manufacturer

Urolithin A brands are evaluating manufacturers on a more specific checklist than commodity ingredient buyers. The ingredient's cost, the sophistication of the target consumer, and the clinical-evidence positioning all raise the stakes on manufacturing partner selection:

• Raw material qualification and incoming testing. Urolithin A has a smaller qualified supplier base than commodity actives. Brands need to know their manufacturer has documented sourcing, incoming QC procedures, and the batch records to prove it. Our cGMP-compliant production protocol covers incoming material identity testing before any batch enters production.
• Third-party potency verification on every batch. The urolithin A category is positioned around dose precision — consumers paying a premium for this ingredient expect their label claim to be accurate. Third-party potency testing with a COA is the documentation that backs that claim. It's standard on every batch Sun produces, not an add-on.
• Capsule fill weight consistency at target dose ranges. 500mg–1,000mg per day means one to two capsules per serving. A manufacturer without calibrated fill procedures will produce inconsistent per-capsule doses across the production run. We verify fill weight throughout production and document the results in the batch record.
• FDA registration and cGMP compliance. Required for any US dietary supplement. Sun's Fort Lauderdale facility is FDA-registered and cGMP-compliant. For longevity-category brands selling to a health-aware consumer who reads labels and checks credentials, this is the baseline expectation before any conversation begins.

Who contracts urolithin A manufacturing with Sun

Urolithin A manufacturing inquiries come from a focused set of brand types — lower total volume than creatine or collagen, but a more sophisticated buyer with a clear category thesis:

• Longevity supplement brands building a full mitochondrial health stack — urolithin A as a standalone SKU or as the anchor of a multi-ingredient formula with NMN, spermidine, or related longevity compounds
• DTC supplement operators moving early into the category before urolithin A becomes a mass-market ingredient — similar positioning playbook to NMN and NAD+ products several years prior
• Functional medicine and practitioner brands adding urolithin A to a longevity protocol product suite for a clinical audience that expects documented ingredient quality
• Amazon supplement brands entering the longevity category with a clean-label, well-documented urolithin A capsule product and needing US manufacturing with full COA documentation per batch
• Established supplement operators adding urolithin A to an existing longevity or wellness portfolio and needing a domestic manufacturing partner with traceable batch records and third-party lab results on every run

Compliance and label claims for urolithin A

Urolithin A supplements are produced and labeled under FDA's structure/function claim framework. Claims that describe how the ingredient supports normal cellular and muscle function are appropriate: "supports mitochondrial health," "promotes mitophagy," "supports muscle function as we age," "maintains cellular energy production." Claims that imply disease treatment, prevention, or reversal — "reverses aging," "prevents sarcopenia," "treats mitochondrial disease" — fall outside the structure/function lane and are not appropriate for dietary supplement labels. We review label copy for compliance before any production commitment.

The urolithin A category's clinical research record makes specific, evidence-grounded structure/function claims defensible. Published research on mitochondrial function, muscle strength outcomes in aging adults, and cellular energy is part of the ingredient's commercial story. The claims on the label need to accurately reflect that research without crossing into disease territory — a distinction we help brands navigate during the production planning process.

Frequently asked questions

See also: NMN Supplement Manufacturer — NAD+ precursor manufacturing that pairs frequently with urolithin A in longevity stacks. For the encapsulation process behind urolithin A programs: Capsule Contract Manufacturer. For Sun's full contract manufacturing overview: Nutraceutical Contract Manufacturing.